Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 1030

Similar articles for PubMed (Select 19733654)

1.

Enhancement in liver SREBP-1c/PPAR-alpha ratio and steatosis in obese patients: correlations with insulin resistance and n-3 long-chain polyunsaturated fatty acid depletion.

Pettinelli P, Del Pozo T, Araya J, Rodrigo R, Araya AV, Smok G, Csendes A, Gutierrez L, Rojas J, Korn O, Maluenda F, Diaz JC, Rencoret G, Braghetto I, Castillo J, Poniachik J, Videla LA.

Biochim Biophys Acta. 2009 Nov;1792(11):1080-6. doi: 10.1016/j.bbadis.2009.08.015. Epub 2009 Sep 4.

2.

Effects on Liver Lipid Metabolism of the Naturally Occurring Dietary Flavone Luteolin-7-glucoside.

Sá C, Oliveira AR, Machado C, Azevedo M, Pereira-Wilson C.

Evid Based Complement Alternat Med. 2015;2015:647832. doi: 10.1155/2015/647832. Epub 2015 May 31.

3.

Herbal SGR Formula Prevents Acute Ethanol-Induced Liver Steatosis via Inhibition of Lipogenesis and Enhancement Fatty Acid Oxidation in Mice.

Qiu P, Li X, Kong DS, Li HZ, Niu CC, Pan SH.

Evid Based Complement Alternat Med. 2015;2015:613584. doi: 10.1155/2015/613584. Epub 2015 May 25.

4.

Improvement in the expression of hepatic genes involved in fatty acid metabolism in obese rats supplemented with taurine.

Bonfleur ML, Borck PC, Ribeiro RA, Caetano LC, Soares GM, Carneiro EM, Balbo SL.

Life Sci. 2015 Jun 17. pii: S0024-3205(15)00310-0. doi: 10.1016/j.lfs.2015.05.019. [Epub ahead of print]

PMID:
26092479
5.

Treatment of rats with Jiangzhi Capsule improves liquid fructose-induced fatty liver: modulation of hepatic expression of SREBP-1c and DGAT-2.

Zhao Y, Pan Y, Yang Y, Batey R, Wang J, Li Y.

J Transl Med. 2015 Jun 2;13:174. doi: 10.1186/s12967-015-0529-6.

6.

Transcriptome profiling identifies p53 as a key player during calreticulin deficiency: Implications in lipid accumulation.

Vig S, Talwar P, Kaur K, Srivastava R, Srivastava AK, Datta M.

Cell Cycle. 2015 May 6:1-11. [Epub ahead of print]

PMID:
25946468
7.

[Effects of transcription factor sterol regulatory element binding protein-1c in palmitate acid-induced L6 cells insulin resistance and its mechanism].

Wu W, Bi Y, Tangsun Y, Yin W, Chen Y, Zhu D.

Zhonghua Yi Xue Za Zhi. 2015 Mar 3;95(8):611-5. Chinese.

PMID:
25917039
8.

Reduction in the desaturation capacity of the liver in mice subjected to high fat diet: Relation to LCPUFA depletion in liver and extrahepatic tissues.

Valenzuela R, Barrera C, Espinosa A, Llanos P, Orellana P, Videla LA.

Prostaglandins Leukot Essent Fatty Acids. 2015 Jul;98:7-14. doi: 10.1016/j.plefa.2015.04.002. Epub 2015 Apr 13.

PMID:
25910408
9.

Inhibition of Dexamethasone-induced Fatty Liver Development by Reducing miR-17-5p Levels.

Du WW, Liu F, Shan SW, Ma XC, Gupta S, Jin T, Spaner D, Krylov SN, Zhang Y, Ling W, Yang BB.

Mol Ther. 2015 Jul;23(7):1222-33. doi: 10.1038/mt.2015.64. Epub 2015 Apr 21.

PMID:
25896250
10.

Pathogenesis of selective insulin resistance in isolated hepatocytes.

Cook JR, Langlet F, Kido Y, Accili D.

J Biol Chem. 2015 May 29;290(22):13972-80. doi: 10.1074/jbc.M115.638197. Epub 2015 Apr 14.

PMID:
25873396
11.

Synthesis and evaluation of fatty acid amides on the N-oleoylethanolamide-like activation of peroxisome proliferator activated receptor α.

Takao K, Noguchi K, Hashimoto Y, Shirahata A, Sugita Y.

Chem Pharm Bull (Tokyo). 2015;63(4):278-85. doi: 10.1248/cpb.c14-00881.

12.

Long-chain polyunsaturated fatty acid status in obesity: a systematic review and meta-analysis.

Fekete K, Györei E, Lohner S, Verduci E, Agostoni C, Decsi T.

Obes Rev. 2015 Jun;16(6):488-97. doi: 10.1111/obr.12280. Epub 2015 Apr 1.

PMID:
25828602
13.

Peroxisome proliferator-activated receptor-α staining is associated with worse outcome in colorectal liver metastases.

Pang T, Kaufman A, Choi J, Gill A, Drummond M, Hugh T, Samra J.

Mol Clin Oncol. 2015 Mar;3(2):308-316. Epub 2014 Dec 30.

14.

Overproduction of altered VLDL in an insulin-resistance rat model: Influence of SREBP-1c and PPAR-α.

Lucero D, Miksztowicz V, Macri V, López GH, Friedman S, Berg G, Zago V, Schreier L.

Clin Investig Arterioscler. 2015 Mar 18. pii: S0214-9168(14)00170-3. doi: 10.1016/j.arteri.2014.11.002. [Epub ahead of print]

PMID:
25796423
15.

Discovery of Novel Anti-Diabetic Drugs by Targeting Lipid Metabolism.

Zhou X, Xu J, Shi Y, Ye JM.

Curr Drug Targets. 2015 Feb 23. [Epub ahead of print]

PMID:
25706109
16.
17.

Fatty acid changes help to better understand regression of nonalcoholic fatty liver disease.

Maciejewska D, Drozd A, Ossowski P, Ryterska K, Jamioł-Milc D, Banaszczak M, Raszeja-Wyszomirska J, Kaczorowska M, Sabinicz A, Stachowska E.

World J Gastroenterol. 2015 Jan 7;21(1):301-10. doi: 10.3748/wjg.v21.i1.301.

18.

Delayed ethanol elimination and enhanced susceptibility to ethanol-induced hepatosteatosis after liver resection.

Liu X, Hakucho A, Liu J, Fujimiya T.

World J Gastroenterol. 2014 Dec 28;20(48):18249-59. doi: 10.3748/wjg.v20.i48.18249.

19.

Eicosapentaenoic acid modulates fatty acid metabolism and inflammation in Psammomys obesus.

Atek-Mebarki F, Hichami A, Abdoul-Azize S, Bitam A, Koceïr EA, Khan NA.

Biochimie. 2015 Feb;109:60-6. doi: 10.1016/j.biochi.2014.12.004. Epub 2014 Dec 18.

PMID:
25528298
20.

A method for long term stabilisation of long chain polyunsaturated fatty acids in dried blood spots and its clinical application.

Liu G, Mühlhäusler BS, Gibson RA.

Prostaglandins Leukot Essent Fatty Acids. 2014 Dec;91(6):251-60. doi: 10.1016/j.plefa.2014.09.009. Epub 2014 Sep 30.

PMID:
25451557
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk